89 related articles for article (PubMed ID: 15725240)
1. Chemotherapy-induced scleroderma: a pleiomorphic syndrome.
Alexandrescu DT; Bhagwati NS; Wiernik PH
Clin Exp Dermatol; 2005 Mar; 30(2):141-5. PubMed ID: 15725240
[TBL] [Abstract][Full Text] [Related]
2. Scleroderma and the taxanes. Is there really a link?
Farrant PB; Mortimer PS; Gore M
Clin Exp Dermatol; 2004 Jul; 29(4):360-2. PubMed ID: 15245529
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic pustular folliculitis induced by chemotherapy.
Laing ME; Laing TA; Mulligan NJ; Keane FM
J Am Acad Dermatol; 2006 Apr; 54(4):729-30. PubMed ID: 16546603
[No Abstract] [Full Text] [Related]
4. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
Shih V; Wan HS; Chan A
Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
[TBL] [Abstract][Full Text] [Related]
5. Leukaemia cutis in a patient treated for breast cancer.
Weinel S; Malone J; Jain D; Callen JP
Australas J Dermatol; 2009 Feb; 50(1):52-5. PubMed ID: 19178494
[TBL] [Abstract][Full Text] [Related]
6. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
[TBL] [Abstract][Full Text] [Related]
7. [Scleroderma-like skin changes following administration of paclitaxel for the treatment of ovarian carcinoma].
Eisenbeilss C; Weizel J; Wolff H
J Dtsch Dermatol Ges; 2003 Jun; 1(6):468-70. PubMed ID: 16295141
[TBL] [Abstract][Full Text] [Related]
8. An intertrigo-like eruption from pegylated liposomal doxorubicin.
Korver GE; Ronald H; Petersen MJ
J Drugs Dermatol; 2006 Oct; 5(9):901-2. PubMed ID: 17039658
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Muss HB; Berry DA; Cirrincione C; Budman DR; Henderson IC; Citron ML; Norton L; Winer EP; Hudis CA;
J Clin Oncol; 2007 Aug; 25(24):3699-704. PubMed ID: 17704418
[TBL] [Abstract][Full Text] [Related]
10. Self limited dermal invasion of keratinocytes in maculopapular eruptions after systemic chemotherapy.
Hann SK; Rhoe BS; Kang WH; Park YK
J Dermatol; 1993 Feb; 20(2):94-101. PubMed ID: 7683027
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
[TBL] [Abstract][Full Text] [Related]
12. Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).
Linden HM; Haskell CM; Green SJ; Osborne CK; Sledge GW; Shapiro CL; Ingle JN; Lew D; Hutchins LF; Livingston RB; Martino S
J Clin Oncol; 2007 Feb; 25(6):656-61. PubMed ID: 17308269
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Gianni L; Baselga J; Eiermann W; Guillem Porta V; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Llombart Cussac A; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez Lopez JJ; Mansutti M; Valagussa P; Bonadonna G;
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8715-21. PubMed ID: 16361558
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological evaluation of preoperative chemotherapy with doxorubicin plus cyclophosphamide followed by paclitaxel for locally advanced breast cancer].
Miyake T; Miyahara S; Fujii K; Taniguchi M; Yamamura K; Tadokoro K; Tanimura M; Nakamura H
Gan To Kagaku Ryoho; 2009 Mar; 36(3):401-5. PubMed ID: 19295263
[TBL] [Abstract][Full Text] [Related]
15. Lipodermatosclerosis as a form of vascular compromise-associated radiation recall dermatitis: case report and a review of literature.
Sroa N; Bartholomew DA; Magro CM
J Cutan Pathol; 2006 Sep; 33 Suppl 2():55-9. PubMed ID: 16972957
[TBL] [Abstract][Full Text] [Related]
16. [Pharmaceutical services for patients receiving AC chemotherapy].
Higuchi M; Matsuo K; Ureshino Y; Ogata K; Futagami K; Kitamura K; Nishino H
Gan To Kagaku Ryoho; 2009 Feb; 36(2):241-5. PubMed ID: 19223738
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous adverse drug reactions during chemotherapy: consider non-antineoplastic drugs.
Bursztejn AC; Tréchot P; Cuny JF; Schmutz JL; Barbaud A
Contact Dermatitis; 2008 Jun; 58(6):365-8. PubMed ID: 18503688
[TBL] [Abstract][Full Text] [Related]
18. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
Trudeau ME; Clemons MJ; Provencher L; Panasci L; Yelle L; Rayson D; Latreille J; Vandenberg T; Goel R; Zibdawi L; Rahim Y; Pouliot JF
J Clin Oncol; 2009 Dec; 27(35):5906-10. PubMed ID: 19858391
[TBL] [Abstract][Full Text] [Related]
19. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.
Tham YL; Sexton K; Weiss H; Elledge R; Friedman LC; Kramer R
Am J Clin Oncol; 2007 Apr; 30(2):126-32. PubMed ID: 17414460
[TBL] [Abstract][Full Text] [Related]
20. Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre.
Bontenbal M; Creemers GJ; Braun HJ; de Boer AC; Janssen JT; Leys RB; Ruit JB; Goey SH; van der Velden PC; Kerkhofs LG; Schothorst KL; Schmitz PI; Bokma HJ; Verweij J; Seynaeve C;
J Clin Oncol; 2005 Oct; 23(28):7081-8. PubMed ID: 16192591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
